查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566355

細胞·基因治療生物分析檢驗服務的全球市場:規模，佔有率，趨勢，產業分析 - 各檢驗類型，各產品類型，各開發階段，各疾病，各地區，市場區隔預測(2024年～2032年)

Cell & Gene Therapy Bioanalytical Testing Services Market Size, Share, Trends, Industry Analysis Report - By Test Type, By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2024-2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，細胞和基因治療生物分析測試服務市場規模預計將達到9.5006億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

越來越多的研究表明細胞和基因療法可以治療多種疾病，這正在推動醫療產業研究工作的投資。該市場正在接受政府資助，以提高藥物和醫療器材的測試能力。例如，2023年3月，英國政府宣布將向國家衛生服務血液和移植局（NHSBT）提供1000萬日元，幫助國家醫療保健服務血液和移植局（NHSBT）開設一個名為臨床生物技術中心（CBC ）的新設施）用於開發和製造新細胞和基因療法宣布將補貼美元。此外，隨著世界各地癌症患者數量的增加，各國都專注於投資細胞和基因治療研究。印度和中國等人口大國正在引進新的癌症治療方法。例如，2024年4月，塔塔紀念中心和印度理工學院（IIT）孟買分校推出了印度首個開發的用於癌症治療的CAR-T細胞療法。這些新的細胞療法正在推動對細胞和基因療法生物分析測試服務的需求，並促進市場成長。

製藥公司越來越主動地增加對細胞和基因療法的設計和生產的投資，這推動了對績效評估工具和服務的需求，這對全球市場產生了積極影響。例如，2024 年 2 月，Azzur Group 宣布推出新的分析實驗室測試服務，作為其細胞和基因療法開發的一部分。這是專門用於測試先進療法和其他醫療產品的。慢性病的增加正在推動研究人員開發有效的藥物。細胞和基因療法的發展進步正在幫助有效治療人們的健康問題。根據美國食品藥物管理局 (FDA) 的統計，有 10 萬人患有鐮狀細胞疾病。因此，世界各地正在開發新的治療方法。 2023年12月，美國FDA宣布核准兩種基因治療藥物Lifgenia和CasGevi用於治療鐮狀細胞疾病。

細胞/基因治療生物分析測試服務市場報告重點

由於製藥創新活動不斷增加，按測試類型劃分的生物利用度和生物等效性測試領域預計將在預測期內呈現最高增長率。

按產品類型劃分，由於多種疾病的細胞療法產量不斷增加，細胞療法領域在 2023 年佔據了最大的市場佔有率。

由於生技產業投資增加，亞太地區預計在預測期內將達到最高成長。

由於對先進治療研究的投資增加，預計在預測期內，歐洲的細胞和基因治療生物分析測試服務市場將出現顯著的複合年增長率。

BioAgilytix Labs、Charles River Laboratories、Intertek Group、IQVIA、KCAS Bioanalytical Services、Pharmaron 是一些全球市場參與者。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球細胞·基因治療生物分析檢驗服務市場洞察

  • 用途概述
  • 細胞·基因治療生物分析檢驗服務市場動態
    • 促進因素和機會
      • 增加對細胞和基因療法開發的投資推動市場成長
      • 細胞和基因療法的不斷發展推動市場成長
    • 阻礙因素與課題
      • 嚴格的監管阻礙市場成長
  • PESTEL分析
  • 細胞·基因治療生物分析檢驗服務市場用途趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球細胞·基因治療生物分析檢驗服務市場:各檢驗類型

  • 主要調查結果
  • 簡介
  • 生物有效性·生物學的同等性的研究
  • 藥物動力學
  • 藥效學
  • 其他

第6章 全球細胞·基因治療生物分析檢驗服務市場:各產品類型

  • 主要調查結果
  • 簡介
  • 基因治療
  • 轉基因細胞療法
  • 細胞療法

第7章 全球細胞·基因治療生物分析檢驗服務市場:各開發階段

  • 主要調查結果
  • 簡介
  • 非臨床
  • 臨床

第8章 全球細胞·基因治療生物分析檢驗服務市場:各疾病

  • 主要調查結果
  • 簡介
  • 感染疾病
  • 神經疾病
  • 腫瘤學
  • 罕見疾病
  • 其他

第9章 全球細胞·基因治療生物分析檢驗服務市場:各地區

  • 主要調查結果
  • 簡介
    • 細胞·基因治療生物分析檢驗服務市場評估:各地區(2019年～2032年)
  • 北美
    • 北美:各檢驗類型(2019年～2032年)
    • 北美:各產品類型(2019年～2032年)
    • 北美:各開發階段(2019年～2032年)
    • 北美:各疾病(2019年～2032年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各檢驗類型(2019年～2032年)
    • 歐洲:各產品類型(2019年～2032年)
    • 歐洲:各開發階段(2019年～2032年)
    • 歐洲:不同症狀(2019年～2032年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各檢驗類型(2019年～2032年)
    • 亞太地區:各產品類型(2019年～2032年)
    • 亞太地區:各開發階段(2019年～2032年)
    • 亞太地區:各疾病(2019年～2032年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各檢驗類型(2019年～2032年)
    • 中東·非洲:各產品類型(2019年～2032年)
    • 中東·非洲:各開發階段(2019年～2032年)
    • 中東·非洲:各疾病(2019年～2032年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各檢驗類型(2019年～2032年)
    • 南美:各產品類型(2019年～2032年)
    • 南美:各開發階段(2019年～2032年)
    • 南美:各疾病(2019年～2032年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 事業擴大和收購的分析
    • 事業擴大
    • 收購
  • 聯盟/合作/契約/公開

第11章 企業簡介

  • BioAgilytix Labs
  • Charles River Laboratories
  • Intertek Group Plc.
  • IQVIA, Inc.
  • KCAS Bioanalytical Services
  • Laboratory Corporation of America Holdings
  • Pharmaron
  • Pharmaceutical Product Development, Inc.
  • Prolytix
  • SGS SA
  • Syneos Health
Product Code: PM5055

The cell & gene therapy bioanalytical testing services market size is expected to reach USD 950.06 million by 2032, according to a new study by Polaris Market Research. The report "Cell & Gene Therapy Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report - By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing number of studies revealing the ability of cell and gene therapies to treat multiple diseases is driving investments in research activities in the healthcare industry. The government funding to increase its capacity to test medication and healthcare equipment in the marketplace. For instance, in March 2023, the UK government announced a grant of USD 10 million for the National Health Service Blood and Transplant (NHSBT) to open a new facility called the Clinical Biotechnology Centre (CBC) for the development and manufacturing of new cell and gene therapies. Furthermore, the growing number of cancer cases across the world is significantly emphasizing countries to invest in cell and gene therapy research. The most populous nations, such as India and China, are launching new therapies for the cancer treatment. For instance, in April 2024, Tata Memorial Centre & Indian Institute of Technology (IIT), Bombay launched India's first developed CAR-T cell therapy for cancer treatment. Thus new cell therapy is boosting demand for cell & gene therapy bioanalytical testing services, which is contributing to market growth.

The rising pharmaceutical companies' initiatives to increase investments in the design and production of cell and gene therapies are driving the demand for performance-evaluating tools and services, which is positively influencing the global market. For instance, in February 2024, Azzur Group announced the new offering of analytical laboratory testing services as a part of developing cell and gene therapy. This is specifically to test advanced therapeutics and other medical products. The increasing prevalence of chronic diseases is encouraging researchers to innovate effective medications. The growing development of cell and gene therapies effectively performs in treating health issues among the population. According to the Food and Drug Administration (FDA), ~100,000 people are suffering from sickle cell disease. This contributed to the design of new therapies around the world. In December 2023, the US FDA announced approval for two gene therapies-Lyfgenia & Casgevy-for the treatment of sickle cell disease.

Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights

The bioavailability & bioequivalence studies segment, by test type is anticipated to witness the highest growth rate during the forecast period due to rising drug innovation activities.

In terms of product type, the cell therapy segment accounted for the largest market share in 2023, owing to the increasing production of cell therapies for several diseases.

APAC is projected to register the highest growth during the forecast period, attributable to the growing investments in the biotechnological industry.

Europe is expected to register a significant CAGR in the cell & gene therapy bioanalytical testing services market during the forecast period due to due increased investment in advanced therapeutic research.

BioAgilytix Labs, Charles River Laboratories, Intertek Group, IQVIA, KCAS Bioanalytical Services, and Pharmaron are among the global market players.

Polaris Market Research has segmented the cell & gene therapy bioanalytical testing services market report on the basis of test type, product type, stage of development, indication, and region:

By Test Type Outlook (Revenue - USD million, 2019-2032)

  • Bioavailability & Bioequivalence Studies
  • Pharmacokinetics
  • Pharmacodynamics
  • Others

By Product Type Outlook (Revenue - USD million, 2019-2032)

  • Gene Therapy
  • Gene-Modified Cell Therapy
  • Cell Therapy

By Stage of Development Outlook (Revenue - USD million, 2019-2032)

  • Nonclinical
  • Clinical

By Indication Outlook (Revenue - USD million, 2019-2032)

  • Oncology
  • Infectious Diseases
  • Neurological Disorders
  • Rare Diseases
  • Others

By Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Insights

  • 4.1. Cell & Gene Therapy Bioanalytical Testing Services Market - Application Snapshot
  • 4.2. Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Investments in Cell and Gene Therapy Developments Drive the Market Growth
      • 4.2.1.2. Growing Development of Cell and Gene Therapies Drives Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulations Hinders the Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell & Gene Therapy Bioanalytical Testing Services Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 5.3. Bioavailability & Bioequivalence Studies
    • 5.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Bioavailability & Bioequivalence Studies, by Region, 2019-2032 (USD Million)
  • 5.4. Pharmacokinetics
    • 5.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacokinetics, by Region, 2019-2032 (USD Million)
  • 5.5. Pharmacodynamics
    • 5.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacodynamics, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 6.3. Gene Therapy
    • 6.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene Therapy, by Region, 2019-2032 (USD Million)
  • 6.4. Gene-Modified Cell Therapy
    • 6.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene-Modified Cell Therapy, by Region, 2019-2032 (USD Million)
  • 6.5. Cell Therapy
    • 6.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Cell Therapy, by Region, 2019-2032 (USD Million)

7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 7.3. Nonclinical
    • 7.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Nonclinical, by Region, 2019-2032 (USD Million)
  • 7.4. Clinical
    • 7.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Clinical, by Region, 2019-2032 (USD Million)

8. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 8.3. Infectious Diseases
    • 8.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 8.4. Neurological disorders
    • 8.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Neurological disorders, by Region, 2019-2032 (USD Million)
  • 8.5. Oncology
    • 8.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 8.6. Rare Diseases
    • 8.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Rare Diseases, by Region, 2019-2032 (USD Million)
  • 8.7. Others
    • 8.7.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Cell & Gene Therapy Bioanalytical Testing Services Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Cell & Gene Therapy Bioanalytical Testing Services Market - North America
    • 9.3.1. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.3.2. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.3.3. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.3.4. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.3.5. Cell & Gene Therapy Bioanalytical Testing Services Market - U.S.
      • 9.3.5.1. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.3.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Canada
      • 9.3.6.1. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4. Cell & Gene Therapy Bioanalytical Testing Services Market - Europe
    • 9.4.1. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.2. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.3. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.4. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.5. Cell & Gene Therapy Bioanalytical Testing Services Market - UK
      • 9.4.5.1. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.6. Cell & Gene Therapy Bioanalytical Testing Services Market - France
      • 9.4.6.1. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.6.2. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.6.3. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.6.4. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Germany
      • 9.4.7.1. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Italy
      • 9.4.8.1. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Spain
      • 9.4.9.1. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.10. Cell & Gene Therapy Bioanalytical Testing Services Market - Netherlands
      • 9.4.10.1. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Russia
      • 9.4.11.1. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.11.2. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.4.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.4.12.2. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.4.12.3. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.4.12.4. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Asia Pacific
    • 9.5.1. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.5. Cell & Gene Therapy Bioanalytical Testing Services Market - China
      • 9.5.5.1. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.5.2. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.5.3. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.5.4. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.6. Cell & Gene Therapy Bioanalytical Testing Services Market - India
      • 9.5.6.1. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.6.2. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.6.3. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.6.4. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Malaysia
      • 9.5.7.1. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.7.2. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.7.3. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.7.4. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Japan
      • 9.5.8.1. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.8.2. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.8.3. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.8.4. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Indonesia
      • 9.5.9.1. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.10. Cell & Gene Therapy Bioanalytical Testing Services Market - South Korea
      • 9.5.10.1. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Australia
      • 9.5.11.1. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.11.2. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.11.3. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.11.4. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.5.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.6.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.6.6. Cell & Gene Therapy Bioanalytical Testing Services Market - UAE
      • 9.6.6.1. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.6.6.2. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.6.6.3. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.6.6.4. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.6.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Israel
      • 9.6.7.1. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.6.8. Cell & Gene Therapy Bioanalytical Testing Services Market - South Africa
      • 9.6.8.1. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.6.8.2. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.6.8.3. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.6.8.4. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.6.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Latin America
    • 9.7.1. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.7.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Mexico
      • 9.7.5.1. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.7.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Brazil
      • 9.7.6.1. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.7.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Argentina
      • 9.7.7.1. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
    • 9.7.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
      • 9.7.8.2. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
      • 9.7.8.3. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
      • 9.7.8.4. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. BioAgilytix Labs
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Charles River Laboratories
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Intertek Group Plc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. IQVIA, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. KCAS Bioanalytical Services
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Laboratory Corporation of America Holdings
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Pharmaron
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Pharmaceutical Product Development, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Prolytix
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. SGS SA
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Syneos Health
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development

List of Tables

  • Table 1 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 2 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 3 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 4 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 5 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 6 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 7 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 8 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 9 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 11 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 12 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 13 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 14 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 15 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 16 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 17 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 18 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 19 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 20 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 21 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 22 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 23 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 24 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 25 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 26 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 27 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 28 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 29 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 30 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 31 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 32 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 33 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 34 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 35 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 36 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 37 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 38 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 39 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 40 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 41 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 42 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 43 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 44 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 45 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 46 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 47 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 48 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 49 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 50 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 51 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 52 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 54 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 55 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 56 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 57 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 58 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 59 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 60 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 61 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 62 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 63 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 64 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 65 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 66 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 67 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 68 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 69 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 70 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 71 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 72 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 73 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 74 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 75 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 76 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 77 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 78 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 79 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 80 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 81 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 82 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 83 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 84 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 85 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 86 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 87 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 88 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 89 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 90 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 91 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 92 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 93 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 94 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 95 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 96 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 97 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 98 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 99 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 100 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 101 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 102 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 103 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 104 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 105 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 106 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 107 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 108 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 109 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 110 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 111 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 112 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 113 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 114 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 115 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 116 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 117 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 118 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 119 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 120 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 121 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 122 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 123 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 124 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 125 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 126 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 127 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 128 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • Table 129 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • Table 130 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • Table 131 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • Table 132 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Test Type
  • Figure 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2023 & 2032 (USD Million)
  • Figure 8. Market by Product Type
  • Figure 9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2023 & 2032 (USD Million)
  • Figure 10. Market by Stage of Development
  • Figure 11. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2023 & 2032 (USD Million)
  • Figure 12. Market by Indication
  • Figure 13. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2023 & 2032 (USD Million)